You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DLBCL, nos Genetic Subtypes

Showing 1 - 25 of 8,543
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

Recruiting
  • B-Cell Lymphoma
  • +4 more
  • 19(T2)28z1xx TRAC T cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023

B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)

Recruiting
  • B-ALL
  • +10 more
  • 131-I Apamistamab
  • CAR T-cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 7, 2022

DLBCL - Diffuse Large B Cell Lymphoma, Lymphoma Trial in Shanghai (Other)

Not yet recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Lymphoma
  • Other
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Sep 6, 2023

Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
  • Phoenix, Arizona
  • +10 more
Feb 1, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Molecular Classification of Relapsed/Refractory Diffuse Large

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Gene Expression Profiling
  • Gene expression profile
  • Shanghai, Shanghai, China
    Yian Zhang
Mar 31, 2022

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
    • Copenhagen, Denmark
      Department of Hematology, Rigshospitalet
    Jan 12, 2022

    Orelabrutinib in Combination With Standard Treatment Regimen for

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Aug 23, 2023

    Alcohol Use Disorder Trial ([18F]NOS)

    Not yet recruiting
    • Alcohol Use Disorder
    • (no location specified)
    May 22, 2023

    Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

    Recruiting
    • Pediatric Soft Tissue Sarcoma
    • detection and monitoring of cirulating tumor DNA
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 20, 2023

    Circadian Rhythm and Other Factors in Memory Clinic Patients

    Not yet recruiting
    • Dementia
    • Questionnaire
    • +3 more
    • Paris, France
    • +1 more
    Aug 3, 2023

    Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

    Recruiting
    • Diffuse Large B Cell Lymphoma，DLBCL
    • PM 8.4 mg/m2
    • PM 11.2 mg/m2
    • Chengdu, Sichuan, China
      West China Hospital Sichuan University
    Jan 15, 2023

    DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Including miRNA-based Tumor Signatures in Diffuse Large B Cell

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • Relapsed Non-Hodgkin Lymphoma
      • no intervention (observational study)
      • Napoli, Italy
      • +2 more
      Feb 17, 2023

      Novel Subtypes of Polycystic Ovary Syndrome

      Recruiting
      • Polycystic Ovary Syndrome
      • Long-term follow-up
      • Hershey, Pennsylvania
      • +10 more
      Nov 4, 2023

      Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +4 more
      • Duarte, California
      • +3 more
      Jul 21, 2022

      Hematologic Cancer Trial in Israel, United States (ABBV-101)

      Not yet recruiting
      • Hematologic Cancer
      • Lone Tree, Colorado
      • +7 more
      Feb 22, 2023

      Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

      Recruiting
      • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
      • With and Without MyD88 and/or CD79B Mutations
      • Evanston, Illinois
      • +6 more
      Dec 12, 2022

      A Study of People With CD30 Positive Lymphoma in China

      Not yet recruiting
      • Lymphoma
        • (no location specified)
        Aug 17, 2022

        Diffuse Large B Cell Lymphoma Trial in Berlin (Ibrutinib and Bortezomib + R-CHOP)

        Active, not recruiting
        • Diffuse Large B Cell Lymphoma
        • Ibrutinib and Bortezomib + R-CHOP
        • Berlin, Germany
          Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
        Aug 10, 2022

        Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma (DLBCL)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Sep 18, 2023

        Mild Cognitive Impairment(MCI), Alzheimer, Late Onset, Familial Alzheimer (FAD) Trial in China

        Recruiting
        • Mild Cognitive Impairment(MCI)
        • +5 more
          • Hefei, Anhui, China
          • +64 more
          Jan 2, 2023